feed,title,long_url,short_url
SeekingAlpha,Nutanix updates on $750M Bain investment,https://seekingalpha.com/news/3617225,
SeekingAlpha,"Prelude Therapeutics prices IPO at $19, higher end of expected range of $17-$19",https://seekingalpha.com/news/3617243,
SeekingAlpha,First Patient enrolled in GENFITs' Phase 3 ELATIVE study for Elafibranor in PBC; shares jumps 13%,https://seekingalpha.com/news/3617239,
SeekingAlpha,Gilead's Jyseleca Ok'd in Japan for rheumatoid arthritis,https://seekingalpha.com/news/3617242,
